Eye | St. Louis Public Radio


Cataracts are the leading cause of blindness worldwide.
National Eye Institute, National Institutes of Health

Scientists have identified a chemical that could one day be used in eye drops to treat cataracts — potentially eliminating the need for expensive surgery, the only treatment option currently available.

The research team was led by the University of Michigan in Ann Arbor but included researchers from the University of Washington in Seattle and Washington University in St. Louis. The group found that eye drops made with a type of steroid could partially reverse cataracts in mice.

This article first appeared in the St. Louis Beacon: “There is writing on that blackboard!”

“Hey, those people on stage have features on their faces!”

“I don’t really have to read the newspaper from across the room!”

(via Flickr/orangeacid)

The U.S. Food and Drug Administration has given St. Louis-based Mobius Therapeutics LLC the go-ahead to start production of a drug for use in eye surgery.

Mobius plans to have other St. Louis-area companies make and distribute the new drug, called Mitosol, which is FDA-approved for use in surgeries to treat glaucoma. Glaucoma is one of the leading causes of blindness in the United States.

Free screening helps young eyes

Jun 26, 2008
Among the children who have been helped by the Lions eye screening is Lauren Simpkins. 300 pixels. 2008
Provided Missouri Lions Eye Research

This article first appeared in the St. Louis Beacon: June 26, 2008 - Starting school and learning how to read is difficult for most children, but almost impossible for students who must struggle simply to see what is written on a page or the chalkboard.

Many children with undiagnosed visual impairments such as amblyopia, farsightedness or nearsightedness struggle with their school activities. Some visually impaired students, whose visual problems go undiagnosed, are incorrectly identified as having learning delays.